Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: Contrasting effects of GLP-1

Biochemical Pharmacology

Volumn 63, Issue 5, 2002, Pages 993-996

  Idris, Iskandar ^a   Patiag, Divina ^a   Gray, Samuel ^a   Donnelly, Richard ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

3T3 adipocytes; Exendin 4; GLP 1; Insulin sensitivity; L6 myotubes

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DEOXYGLUCOSE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RECEPTOR; UNCLASSIFIED DRUG; WORTMANNIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HORMONE TRANSPORT; INSULIN LIKE ACTIVITY; INSULIN SENSITIVITY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DRUG INTERACTIONS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; INSULIN RESISTANCE; MUSCLE, SKELETAL; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN PRECURSORS; RATS; TUMOR CELLS, CULTURED; VENOMS;

EID: 0036496551     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00924-8     Document Type: Article

References (20)

1. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagons-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations
2. Reduced postprandial concentrations of intact biologically active glucagons like peptide-1 in Type 2 diabetic patients
3. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagons like peptide-1-(7-36) amide in type II (noninsulin-dependent) diabetic patients
4. Glucagonostatic and insulinotropic action of glucagon-like peptide-1 (7-36) amide
5. Antidiabetogenic effect of glucagons like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus
6. Isolation and characterization of exendin-4, an exendin-3 analogue from Heloderma suspectum venom
7. Tissue specific expression of unique mRNAs that encode proglucagon-derived peptides on exendin-4 in the lizard
8. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide-1-(7-36)-amide receptor of insulin-secreting β-cells
9. Once-daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations
10. Glucose-lowering and insulin-sensitizing actions of exendin-4: Studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca Mulatta)
11. Possible interactions between angiotensin II and insulin: Effects on glucose and lipid metabolism in vivo and in vitro
12. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor
13. Glucagon-like peptide 1 (7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: One of several potential extrapancreatic sites of GLP-1 action
14. Exendin-4 agonist and exendin (9-39) amide antagonist of the GLP-1 (7-36) amide effects in liver and muscle
15. The effect of glucagon-like peptide-1 (GLP-1) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones
16. Essential role of phosphatidylinositol 3-kinase in insulin induced glucose transport and antilipolysis in rat adipocytes - Studies with a selective inhibitor wortmannin
17. MAP-kinase inhibition does not block the stimulation of glucose utilization by insulin
18. Cloning and functional expression of the human islet GLP-1 receptor: Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor
19. Tissue distribution of messenger ribonucleic acid encoding the rat glucagons-like peptide-1 receptor
20. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes